Glutes Gluts - Gluts.com

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced that it has filed an Investigational New Drug ("IND") application for COL-172, a tamper-resistant, extended-release oral opioid formulation intended to treat moderate to severe pain in individuals who require around-the-clock opioid therapy for an extended period of time...